+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Middle East and Africa Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type and Route of administration, and County

  • ID: 5231387
  • Report
  • November 2020
  • Region: Middle East, Africa
  • 87 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021
1 of 3

FEATURED COMPANIES

  • BHARAT BIOTECH
  • GlaxoSmithKline plc
  • Pax Vax Inc
  • Sanofi
  • MORE
According to a new market research study of “Middle East and Africa Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Analysis by Vaccine Type and Route Of Administration, Middle East and Africa typhoid fever vaccines market is projected to reach US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow at CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the Middle East and Africa typhoid fever vaccines market and the factors driving market along with those that act as hindrances.

The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.

Middle East and Africa typhoid fever vaccines market is expected to grow owing to growing initiatives for typhoid fever in Middle East and Africa region. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.

Leading companies operating in the Middle East and Africa typhoid fever vaccines market are includes GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, BHARAT BIOTECH among others.

The report segments Middle East and Africa Typhoid Fever Vaccines market as follows:

By Vaccine Type
  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others
By Route of Administration
  • Oral
  • Injectable
By Country
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
Reasons to Buy
  • To understand the Middle East and Africa typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa typhoid fever vaccines market.
  • Efficiently plan M&A and partnership deals in Middle East and Africa typhoid fever vaccines market by identifying market segments with the most promising probable sales.
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments from Middle East and Africa typhoid fever vaccines market.
  • Obtain market revenue forecast for market by various segments from 2019-2027 in Middle East and Africa.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BHARAT BIOTECH
  • GlaxoSmithKline plc
  • Pax Vax Inc
  • Sanofi
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Typhoid Fever Vaccines Market - by Vaccine Type
1.3.2 Middle East and Africa Typhoid Fever Vaccines Market - by Route of Administration
1.3.3 Middle East and Africa Typhoid Fever Vaccines Market - by Country

2. Middle East and Africa Typhoid Fever Vaccines Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East and Africa Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa Typhoid Fever Vaccines Market - Middle East and Africa PEST Analysis
4.3 Expert Opinion

5. Middle East and Africa Typhoid Fever Vaccines Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Initiatives for Typhoid Fever in Middle East and Africa Region
5.2 Key Restraints
5.2.1 Risks Associated with Typhoid Fever Vaccines
5.3 Key Market Opportunities
5.3.1 Growing Pharmaceutical Industry in Middle East
5.4 Future Trend
5.4.1 The Growing Trend of Conjugate Vaccine
5.5 Impact Analysis

6. Typhoid Fever Vaccines Market - Middle East and Africa Analysis
6.1 Middle East and Africa Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7. Typhoid Fever Vaccines Market - by Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.3.1 Overview
7.3.2 Live Attenuated Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Capsular Polysaccharide Vaccines
7.5.1 Overview
7.5.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Conjugate Vaccine
7.6.1 Overview
7.6.2 Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

8. Typhoid Fever Vaccines Market Analysis - by Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.2.1.1 Overview
8.2.2 Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

9. Typhoid Fever Vaccines Market Revenue and Forecasts to 2027 - Geographical Analysis
9.1 Middle East and Africa: Typhoid Fever Vaccines Market
9.1.1 Overview
9.1.2 Middle East and Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Middle East and Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
9.1.4 Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.1.5 Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.1.6 Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.1.7 UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UAE: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 UAE: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.1.8 South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 South Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 South Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.1.9 Rest of Middle East & Africa (MEA): Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Rest of MEA: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
9.1.9.3 Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
10.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Shanghai Institute of Biological Products Co., Ltd.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sanofi
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Paxvax Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bharat Biotech
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 GlaxoSmithKline plc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

List of Tables
Table 1. Middle East & Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 5. UAE: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 6. UAE: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. South Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 8. South Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 9. Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Glossary of Terms, Middle East and Africa Typhoid Fever Vaccines Market

List of Figures
Figure 1. Typhoid Fever Vaccines Market Segmentation
Figure 2. Middle East and Africa Typhoid Fever Vaccines Market Overview
Figure 3. Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market
Figure 4. Saudi Arabia is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Middle East and Africa Typhoid Fever Vaccines Market - Leading Country Markets (US$ Mn)
Figure 6. Middle East and Africa : PEST Analysis
Figure 7. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints
Figure 8. Middle East and Africa Typhoid Fever Vaccines Market - Revenue Forecasts and Analysis-2019-2027
Figure 9. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
Figure 10. Live Attenuated Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 15. Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Middle East and Africa: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 18. Middle East and Africa: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
Figure 19. Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 20. Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 21. UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 22. South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 23. Rest of MEA: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 24. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Middle East and Africa Countries
Note: Product cover images may vary from those shown
3 of 3
  • GlaxoSmithKline plc
  • Shanghai institute of biological products co. ltd.
  • Sanofi
  • Pax Vax Inc
  • BHARAT BIOTECH
Note: Product cover images may vary from those shown
Adroll
adroll